From Surf Wiki (app.surf) — the open knowledge base

Medicines and Related Substances Control Amendment Act, 1997

Law in South Africa to fight the HIV/AIDS epidemic

Field	Value
short_title	Medicines and Related Substance 1997
legislature
enacted_by	Government of South Africa
date_enacted	1997
date_assented
royal_assent
date_signed
signed_by
date_commenced
date_effective
amends
repeals
amended_by
repealed_by
related_legislation
status	Current

South Africa's Medicines and Related Substance 1997 is a law enacted a compulsory license in order to fight HIV/AIDS epidemic. The intent of the Act was to reduce drug prices by allowing generic substitution of off-patent drugs, the parallel importation of on-patent drugs as well as price transparency. TOC

Enactment

In an effort to combat the growing HIV/AIDS epidemic, the Government of South Africa enacted the Medicines and Related Substances Control Amendment Act in 1997. The Act aimed to both reduce the cost of drugs and increase their availability.

Challenge to the Law

In February 1998, the South African Pharmaceutical Manufactures Association and forty Multinational Corporations (MNC) brought a suit against the government of South Africa for its passage of the Medicines and Related Substances Control Amendment Act No. 90 of 1997, arguing that it violated the Agreement on Trade-Related Aspects of Intellectual Property Rights. The intent of the Act was to reduce drug prices by allowing generic substitution of off-patent drugs, the parallel importation of on-patent drugs as well as price transparency.

In agreement with the suit, the United States (US) and European Communities (EC) threatened economic sanctions. However, HIV/AIDS activists successfully contested this, demonstrators alleging that then United States presidential-candidate Al Gore was killing babies in Africa—and forced the US and EC to back off the South African government. As a result of immense international pressure, including from NGOs such as Oxfam, the pharmaceutical companies dropped their case in April 2001.

References

"MEDICINES AND RELATED SUBSTANCES CONTROL ACT 101 OF 1965".
Duane Nash, “South Africa's Medicines and Related Substances Control Amendment Act of 1997,” Berkeley Technology Law Journal 15 (2002): 485-504
(24 February 2001). "Drug companies sue South African government over generics". BMJ: British Medical Journal.
(2002). "TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha". Chicago Journal of International Law.
(1 February 2001). "South Africa vs. the Drug Giants: A challenge to affordable medicines".
(28 April 2001). "Drug companies withdraw law suit against South Africa". BMJ: British Medical Journal.

Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

drugs-in-south-africa hiv/aids-in-south-africa south-african-legislation 1997-in-south-african-law

Want to explore this topic further?

Ask Mako anything about Medicines and Related Substances Control Amendment Act, 1997 — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report